Mabtas N 500 mg Injection is used in the treatment of Non-Hodgkin&#039;s disease, rheumatoid arthritis, chronic lymphocytic leukaemia, granulomatosis and pemphigus vulgaris. The detailed uses of Mabtas N 500 mg Injection are as follows:&lt;br/&gt;&bull; Non-Hodgkin&rsquo;s Lymphoma (NHL): Mabtas N 500 mg Injection is used to treat Non-Hodgkin&rsquo;s Lymphoma alone or with chemotherapy.&lt;br/&gt;&bull; Chronic Lymphocytic Leukemia (CLL): Mabtas N 500 mg Injection is used in the treatment of Chronic Lymphocytic Leukemia (CLL) and B-cell Acute Lymphoblastic Leukemia (B-ALL.&lt;br/&gt;&bull; Rheumatoid Arthritis (RA): Mabtas N 500 mg Injection is used in the treatment of rheumatoid arthritis.&lt;br/&gt;&bull; Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA): Mabtas N 500 mg Injection helps to treat Granulomatosis with Polyangiitis and Microscopic Polyangiitis.&lt;br/&gt;&bull; Pemphigus Vulgaris: Mabtas N 500 mg Injection is used to treat pemphigus vulgaris for moderate to severe cases.&lt;br/&gt;

Medicinal Benefits:

Mabtas N 500 mg Injection contains Rituximab, which belongs to the class of monoclonal antibodies. It works by inhibiting the DNA and RNA transcription that is essential for cancer cell growth. This helps prevent the growth and further spread of cancerous or non-cancerous cells. On the other hand, Mabtas N 500 mg Injection works by interfering with the immune system process that causes inflammation in the joint tissues. Thus, it reduces pain and inflammation and prevents joint damage and disease progression over time.

FAQs

What is the use of Mabtas N 500 mg Injection?

Mabtas N 500 mg Injection is used to treat Non-Hodgkinâ€™s disease, rheumatoid arthritis, chronic lymphocytic leukaemia, granulomatosis and pemphigus vulgaris.

How does Mabtas N 500 mg Injection work?

Mabtas N 500 mg Injection contains Rituximab, which works by inhibiting the DNA and RNA transcription that is essential for cancer cell growth.

What are the conditions to be noted while receiving Mabtas N 500 mg Injection?

Mabtas N 500 mg Injection may cause bowel obstruction and perforation, reactivation of Hepatitis B infection, Cardiac arrhythmias, tumour lysis syndrome, and angina in some patients. Hence, inform your oncologist about your complete medical history, including current medication, to rule out any side effects/interactions.

What is the composition of Mabtas N 500 mg Injection?

Mabtas N 500 mg Injection contains the active substance rituximab. This is a type of protein called a monoclonal antibody.

What are the side effects of Mabtas N 500 mg Injection?

The common side effects of Mabtas N 500 mg Injection are pale skin, painful urination, night sweats, flushing, back pain, nausea, vomiting, diarrhoea, stomach pain, mouth sores, peeling of skin, injection site reactions and pain at the site of injection. If any of these side effects persist or worsen, please consult your doctor.